| Type | Title | Date Released | |
|---|---|---|---|
DEFA14A | Form DEFA14A | ||
DEF 14A | Form DEF 14A | ||
PRE 14A | Form PRE 14A | ||
8-K | 20/20 Biolabs, Inc. Announces Voting Results from Adjourned Annual Meeting for Charter Amendment | ||
8-K | 20/20 Biolabs Receives Nasdaq Deficiency Notifications Regarding Minimum Bid Price and Stockholders' Equity Requirements | ||
8-K | AIDX Investor Update: Regulatory Progress and Commercial Growth for OneTest | ||
DEFA14A | Form DEFA14A | ||
8-K | 20/20 Biolabs, Inc. Announces Annual Meeting Results and Adjournment of Proposal 3 | ||
424B3 | Form 424B3 | ||
424B3 | Form 424B3 | ||
8-K | 20/20 BioLabs Reports Record Q2 2026 Revenue and Operational Growth | ||
10-Q | Form 10-Q |